drugset / Trial / NCT00380523

Analgesic Treatment Mediated by Arcoxia (0663-093)

NCT00380523

Phase 4 Completed 237 enrolled Organon and Co
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Allow physicians to test the efficacy of arcoxia in patients with acute pain.

Timeline

Start
2005-04
Primary completion
2005-05
Completion
2005-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Etoricoxib Small molecule

Indications

No indication recorded.